An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial

被引:7
|
作者
Pickering, Emily [1 ,2 ]
Steels, Elizabeth [1 ,2 ]
Rao, Amanda [3 ]
Steadman, Kathryn J. [1 ]
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia
[2] Evidence Sci Pty Ltd, Brisbane, Qld 4005, Australia
[3] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld 4102, Australia
关键词
Trigonella foenum-graecum; fenugreek; prediabetes; type; 2; diabetes; fasting blood glucose; post-prandial glucose; insulin; FENUGREEK SEEDS; INSULIN-RESISTANCE; BLOOD-GLUCOSE; TYPE-2; L; 4-HYDROXYISOLEUCINE; HYPERGLYCEMIA; STRESS;
D O I
10.3390/pharmaceutics14112453
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: A randomized, double-blind, placebo-controlled trial
    Plourde, PV
    Reiter, EO
    Jou, HC
    Desrochers, PE
    Rubin, SD
    Bercu, BB
    Diamond, FB
    Backeljauw, PF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4428 - 4433
  • [32] The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgiae. A Randomized, Double-blind, Placebo-controlled Trial
    Mease, Philip J.
    Clauw, Daniel J.
    Gendreau, R. Michael
    Rao, Srinivas G.
    Kranzler, Jay
    Chen, Wei
    Palmer, Robert H.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 398 - 409
  • [33] Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial
    Xiang, Yingying
    Shen, Lixuan
    Xue, Yingying
    Wang, Ziwei
    Zhou, Ruonan
    Cao, Yue
    Zhu, Ziwei
    Xu, Pingyuan
    Yu, Xizhong
    Fang, Penghua
    Shang, Wenbin
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5293 - 5303
  • [34] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [35] Efficacy and safety of corticosteroids in the treatment of CP/CPPS: A randomized, double-blind, placebo-controlled trial
    Dimitrakov, JD
    Tchitalov, J
    Dikov, D
    JOURNAL OF UROLOGY, 2004, 171 (04): : 61 - 62
  • [36] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    Croft, Harry A.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S378 - S379
  • [37] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
  • [38] Efficacy and Safety of Nortriptyline in Functional Dyspepsia in Asians: A Randomized Double-Blind Placebo-Controlled Trial
    Kaosombatwattana, Uayporn
    Pongprasobchai, Supot
    Limsrivilai, Julajak
    Leelakusolvong, Somchai
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2015, 148 (04) : S822 - S822
  • [39] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Croft, Harry A.
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : E1291 - E1298
  • [40] Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial
    Kaosombatwattana, Uayporn
    Pongprasobchai, Supot
    Limsrivilai, Julajak
    Maneerattanaporn, Monthira
    Leelakusolvong, Somchai
    Tanwandee, Tawesak
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (02) : 411 - 417